Indefinite Delivery Contract SPE2DU25D9380

The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The original contract opportunity, a pre-solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), aims to establish multiple Prime Vendor Contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, the United States Coast Guard, Designated Providers, and Other Government Agencies. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items, to ensure resiliency in the DoD's pharmaceutical supply chain.